HDAC4: Mechanism of regulation and biological functions

Epigenomics

Volumn 6, Issue 1, 2014, Pages 139-150

  Wang, Zhengke ^a   Qin, Gangjian ^b   Zhao, Ting C ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Function; HAT; HDAC4; Modification; Regulation

Indexed keywords

CARRIER PROTEIN; CASPASE 2; CASPASE 3; CYSTEINE; DNA BINDING PROTEIN; DUAL SPECIFICITY PHOSPHATASE 2; FOLLISTATIN; HISTONE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE H3; HYBRID PROTEIN; LYSINE; MICRORNA 1; MICRORNA 155; MICRORNA 200A; MICRORNA 22; MICRORNA 29; NONHISTONE PROTEIN; NUCLEOPORIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN 14 3 3; REACTIVE OXYGEN METABOLITE; SERUM RESPONSE FACTOR; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; TYROSINE;

3' UNTRANSLATED REGION; ACUTE LEUKEMIA; ALBRIGHT SYNDROME; AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANGIOGENESIS; APOPTOSIS; ASSOCIATION; ATAXIA TELANGIECTASIA; AUTISM; B CELL LYMPHOMA; BINDING SITE; BLADDER; BLADDER TUMOR; BRACHYDACTYLY; BRAIN CELL CULTURE; BREAST CANCER; CANCER GROWTH; CARBONYLATION; CARCINOGENICITY; CARDIOVASCULAR DISEASE; CARTILAGE CELL; CASTRATION RESISTANT PROSTATE CANCER; CELL DEATH; CELL FUNCTION; CELL GROWTH; CELL LINEAGE; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHROMATIN CONDENSATION; CHROMOSOME 1; CHROMOSOME TRANSLOCATION; CODOMINANCE; COLON CANCER; COVALENT BOND; CYTOPLASM; DEACETYLATION; DEGENERATIVE DISEASE; DEMETHYLATION; DENTATE GYRUS; DISULFIDE BOND; DNA SEQUENCE; EMBRYONIC STEM CELL; ENCHONDRAL OSSIFICATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME REGULATION; EUCHROMATIN; FIBROBLAST; GC RICH SEQUENCE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENE REPRESSION; GENETIC TRANSCRIPTION; GLYCOLYSIS; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HISTONE ACETYLATION; HUMAN; HUNTINGTON CHOREA; HYPERTENSION; HYPERTROPHY; INTESTINE EPITHELIUM; LEUKEMIA CELL; LIVER CELL CARCINOMA; LYMPHOMA CELL; MALIGNANT NEOPLASTIC DISEASE; MENTAL DEFICIENCY; MENTAL DISEASE; MESODERM; METASTASIS; MORPHOGENESIS; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOFILAMENT; MYOTUBE; NERVE DEGENERATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; OVARY CANCER; OXIDATIVE STRESS; PHASE 3 CLINICAL TRIAL (TOPIC); PHENOTYPE; PHOSPHORYLATION AND DEPHOSPHORYLATION; PHOTORECEPTOR; POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REGULATORY MECHANISM; RETINA DEGENERATION; REVIEW; SCHIZOPHRENIA; SEIZURE; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE; STEM CELL; SUMOYLATION; SURVIVAL FACTOR; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSIENT TRANSFECTION; TRANSITIONAL CELL CARCINOMA; TUMOR BIOPSY; TUMOR GROWTH; UBIQUITINATION; UPREGULATION;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CHONDROGENESIS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HUMANS; MICE; MICRORNAS; MUSCLE DEVELOPMENT; NEOPLASMS; REPRESSOR PROTEINS;

EID: 84895440984     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.13.73     Document Type: Review

References (99)

1. Thiagalingam S, Cheng KH, Lee HJ et al. Histone deacetylases: Unique players in shaping the epigenetic histone code. Ann. NY Acad. Sci. 983, 84-100 (2003
2. Grozinger CM, Schreiber SL. Deacetylase enzymes: Biological functions and the use of small-molecule inhibitors. Chem. Biol. 9, 3-16 (2002
3. Chen HP, Denicola M, Qin X et al. HDAC inhibition promotes cardiogenesis and the survival of embryonic stem cells through proteasome-dependent pathway. J. Cell Biochem. 112, 3246-3255 (2011
4. Vaquero A, Sternglanz R, Reinberg D. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 26, 5505-5520 (2007
5. Fischle W, Kiermer V, Dequiedt F et al. The emerging role of class II histone deacetylases. Biochem. Cell Biol. 79, 337-348 (2001
6. Martin M, Kettmann R, Dequiedt F. Class IIa histone deacetylases: Regulating the regulators. Oncogene 26, 5450-5467(2007
7. Yang XJ, Seto E. The Rpd3/Hda1 family of lysine deacetylases: From bacteria and yeast to mice and men. Nat. Rev. Mol. Cell Biol. 9, 206-218 (2008
8. Barneda-Zahonero B, Parra M. Histone deacetylases and cancer. Mol. Oncol. 6, 579-589 (2012
9. Wang AH, Bertos NR, Vezmar M et al. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell. Biol. 19, 7816-7827 (1999
10. Vega RB, Matsuda K, Oh J et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555-566 (2004
11. Stark M, Hayward N. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res. 67, 2632-2642 (2007
12. Liu F, Pore N, Kim M et al. Regulation of histone deacetylase 4 expression by the SP family of transcription factors. Mol. Biol. Cell 17, 585-597(2006
13. Addis RC, Prasad MK, Yochem RL et al. OCT3/4 regulates transcription of histone deacetylase 4 (Hdac4) in mouse embryonic stem cells. J. Cell. Biochem. 111, 391-401(2010
14. Yuan JH, Yang F, Chen BF et al. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma. Hepatology 54, 2025-2035 (2011
15. Chen JF, Mandel EM, Thomson JM et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233 (2006
16. Sun Y, Ge Y, Drnevich J et al. Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J. Cell Biol. 189, 1157-1169 (2010
17. Sluijter JP, van Mil A, van Vliet P et al. MicroRNA-1 and-499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arterioscler. Thromb. Vasc. Biol. 30, 859-868(2010
18. Zhang J, Yang Y, Yang T et al. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer 103, 1215-1220 (2010
19. Winbanks CE, Wang B, Beyer C et al. TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J. Biol. Chem. 286, 13805-13814 (2011
20. Tuddenham L, Wheeler G, Ntounia-Fousara S et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 580, 4214-4217(2006
21. Miyaki S, Sato T, Inoue A et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 24, 1173-1185(2010
22. Guan YJ, Yang X, Wei L et al. MiR-365: A mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J. 25, 4457-4466 (2011
23. Sandhu SK, Volinia S, Costinean S et al. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Emu-miR-155 transgenic mouse model. Proc. Natl Acad. Sci. USA 109, 20047-20052(2013
24. Guo L, Han A, Bates DL et al. Crystal structure of a conserved N-Terminal domain of histone deacetylase 4 reveals functional insights into glutamine-rich domains. Proc. Natl Acad. Sci. USA 104, 4297-4302 (2007
25. Bottomley MJ, Lo Surdo P, Di Giovine P et al. Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J. Biol. Chem. 283, 26694-26704 (2008
26. Grozinger CM, Schreiber SL. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97, 7835-7840 (2000
27. Wang AH, Kruhlak MJ, Wu J et al. Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell Biol. 20, 6904-6912 (2000
28. McKinsey TA, Zhang CL, Lu J et al. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111(2000
29. Backs J, Song K, Bezprozvannaya S et al. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853-1864 (2006
30. Nakagawa Y, Kuwahara K, Harada M et al. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. J. Mol. Cell. Cardiol. 41, 1010-1022 (2006
31. Backs J, Backs T, Neef S et al. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc. Natl Acad. Sci. USA 106, 2342-2347 (2009
32. Zhang T, Kohlhaas M, Backs J et al. CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J. Biol. Chem. 282, 35078-35087 (2007
33. Backs J, Worst BC, Lehmann LH et al. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J. Cell Biol. 195, 403-415 (2011
34. Zhou X, Richon VM, Wang AH et al. Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras. Proc. Natl Acad. Sci. USA 97, 14329-14333 (2000
35. Cernotta N, Clocchiatti A, Florean C et al. Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility. Mol. Biol. Cell 22, 278-289 (2011
36. Paroni G, Cernotta N, Dello Russo C et al. PP2A regulates HDAC4 nuclear import. Mol. Biol. Cell 19, 655-667 (2008
37. Ago T, Liu T, Zhai P et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 133, 978-993 (2008
38. Matsushima S, Kuroda J, Ago T et al. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ. Res. 112, 651-663 (2013
39. Tatham MH, Jaffray E, Vaughan OA et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368-35374 (2001
40. Kirsh O, Seeler JS, Pichler A et al. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21, 2682-2691 (2002
41. Liu F, Dowling M, Yang XJ et al. Caspase-mediated specific cleavage of human histone deacetylase 4. J. Biol. Chem. 279, 34537-34546 (2004
42. Paroni G, Fontanini A, Cernotta N et al. Dephosphorylation and caspase processing generate distinct nuclear pools of histone deacetylase 4. Mol. Cell. Biol. 27, 6718-6732 (2007
43. Paroni G, Mizzau M, Henderson C et al. Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol. Biol. Cell. 15, 2804-2818 (2004
44. Kozhemyakina E, Cohen T, Yao TP et al. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway. Mol. Cell. Biol. 29, 5751-5762 (2009
45. McKinsey TA, Zhang CL, Olson EN. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol. Cell. Biol. 21, 6312-6321 (2001
46. McKinsey TA, Kuwahara K, Bezprozvannaya S et al. Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK. Mol. Biol. Cell. 17, 438-447 (2006
47. Wang AH, Yang XJ. Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol. Cell. Biol. 21, 5992-6005 (2001
48. Kehat I, Accornero F, Aronow BJ et al. Modulation of chromatin position and gene expression by HDAC4 interaction with nucleoporins. J. Cell. Biol. 193, 21-29 (2011
49. Qian DZ, Kachhap SK, Collis SJ et al. Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha. Cancer Res. 66, 8814-8821 (2006
50. Seo HW, Kim EJ, Na H et al. Transcriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1. FEBS Lett. 583, 55-60 (2009
51. Geng H, Harvey CT, Pittsenbarger J et al. HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia. J. Biol. Chem. 286, 38095-38102 (2011
52. Choi MC, Cohen TJ, Barrientos T et al. A direct HDAC4-MAP kinase crosstalk activates muscle atrophy program. Mol. Cell 47, 122-132 (2012
53. Stronach EA, Alfraidi A, Rama N et al. HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer. Cancer Res. 71, 4412-4422 (2011
54. Fischle W, Dequiedt F, Hendzel MJ et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 9, 45-57 (2002
55. Guenther MG, Barak O, Lazar MA. The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol. Cell Biol. 21, 6091-6101 (2001
56. Jeon EJ, Lee KY, Choi NS et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J. Biol. Chem. 281, 16502-16511 (2006
57. Shinkai Y. Regulation and function of H3K9 methylation. Subcell. Biochem. 41, 337-350 (2007
58. Zhang CL, McKinsey TA, Olson EN. Association of class II histone deacetylases with heterochromatin protein 1: Potential role for histone methylation in control of muscle differentiation. Mol. Cell. Biol. 22, 7302-7312 (2002
59. Raychaudhuri N, Raychaudhuri S, Thamotharan M et al. Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring. J. Biol. Chem. 283, 13611-13626 (2008
60. Hohl M, Wagner M, Reil JC, Tauchnitz M, Zimmer AM, Lehmann LH, Thiel G, Bohm M, Backs J, Maack C et al. HDAC4 controls histone methylation in response to elevated cardiac load. J. Clin. Invest. 123, 1359-1370 (2013
61. Sailaja BS, Cohen-Carmon D, Zimmerman G et al. Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4. Proc. Natl Acad. Sci. USA 109, E3687-E3695 (2012
62. Huang SK, Scruggs AM, Donaghy J et al. Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts. Cell Death Dis. 4, e621 (2013
63. Gregoire S, Tremblay AM, Xiao L et al. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem. 281, 4423-4433 (2006
64. Zhao X, Sternsdorf T, Bolger TA et al. Regulation of MEF2 by histone deacetylase 4-And SIRT1 deacetylase-mediated lysine modifications. Mol. Cell Biol. 25, 8456-8464 (2005
65. Gregoire S, Yang XJ. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell Biol. 25, 2273-2287 (2005
66. Kang JS, Alliston T, Delston R et al. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 24, 2543-2555 (2005
67. Pei M, Chen D, Li J et al. Histone deacetylase 4 promotes TGF-beta1-induced synovium-derived stem cell chondrogenesis but inhibits chondrogenically differentiated stem cell hypertrophy. Differentiation 78, 260-268 (2009
68. Lin Q, Schwarz J, Bucana C et al. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276, 1404-1407 (1997
69. Karamboulas C, Swedani A, Ward C et al. HDAC activity regulates entry of mesoderm cells into the cardiac muscle lineage. J. Cell. Sci. 119, 4305-4314 (2006
70. McKinsey TA, Zhang CL, Olson EN. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl Acad. Sci. USA 97, 14400-14405 (2000
71. Miska EA, Langley E, Wolf D et al. Differential localization of HDAC4 orchestrates muscle differentiation. Nucleic Acids Res. 29, 3439-3447 (2001
72. Liu Y, Randall WR, Schneider MF. Activity-dependent and-independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle. J. Cell Biol. 168, 887-897 (2005
73. Passier R, Zeng H, Frey N et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395-1406 (2000
74. Huang ZP, Chen J, Seok HY et al. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ. Res. 112, 1234-1243 (2013
75. Gupta MP, Samant SA, Smith SH et al. HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. J. Biol. Chem. 283, 10135-10146 (2008
76. Cohen TJ, Barrientos T, Hartman ZC et al. The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity. FASEB J. 23, 99-106 (2009
77. Cohen TJ, Waddell DS, Barrientos T et al. The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J. Biol. Chem. 282, 33752-33759 (2007
78. Tang H, Macpherson P, Marvin M et al. A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression. Mol. Biol. Cell 20, 1120-1131 (2009
79. Darcy MJ, Calvin K, Cavnar K et al. Regional and subcellular distribution of HDAC4 in mouse brain. J. Comp. Neurol. 518, 722-740 (2010
80. Bolger TA, Yao TP. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J. Neurosci. 25, 9544-9553 (2005
81. Bolger TA, Zhao X, Cohen TJ et al. The neurodegenerative disease protein ataxin-1 antagonizes the neuronal survival function of myocyte enhancer factor-2. J. Biol. Chem. 282, 29186-29192 (2007
82. Chawla S, Vanhoutte P, Arnold FJ et al. Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J. Neurochem. 85, 151-159 (2003
83. Jovicic A, Zaldivar Jolissaint JF et al. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-Apoptotic effects and may also target specific Huntington's disease-related mechanisms. PLoS ONE 8, e54222 (2013
84. Chen B, Cepko CL. HDAC4 regulates neuronal survival in normal and diseased retinas. Science 323, 256-259 (2009
85. Yang Y, Qin X, Liu S et al. Peroxisome proliferator-Activated receptor gamma is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress. J. Neurochem. 118, 429-439 (2011
86. Williams SR, Aldred MA, Der Kaloustian VM et al. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am. J. Hum. Genet. 87, 219-228 (2010
87. Kim T, Park JK, Kim HJ et al. Association of histone deacetylase genes with schizophrenia in Korean population. Psychiatry Res. 178, 266-269 (2012
88. Li J, Chen J, Ricupero CL et al. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat. Med. 18, 783-790 (2013
89. Lenoir O, Flosseau K, Ma FX et al. Specific control of pancreatic endocrine beta-And delta-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9. Diabetes 60, 2861-2871(2011
90. Chauchereau A, Mathieu M, de Saintignon J et al. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-Associated protein PLZF. Oncogene 23, 8777-8784 (2004
91. Lemercier C, Brocard MP, Puvion-Dutilleul F et al. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J. Biol. Chem. 277, 22045-22052 (2002
92. Wilson AJ, Byun DS, Nasser S et al. HDAC4 promotes growth of colon cancer cells via repression of p21. Mol. Biol. Cell 19, 4062-4075 (2008
93. Mottet D, Pirotte S, Lamour V et al. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene 28, 243-256 (2009
94. Liu R, Wang L, Chen G et al. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Res. 69, 2252-2259 (2009
95. Barrett A, Santangelo S, Tan K et al. Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases. Int. J. Cancer 121, 265-275 (2007
96. Xu XS, Wang L, Abrams J et al. Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer. J. Hematol. Oncol. 4, 17 (2011
97. Geng H, Harvey CT, Pittsenbarger J et al. HDAC4 protein regulates HIF1alpha protein lysine acetylation and cancer cell response to hypoxia. J. Biol. Chem. 286, 38095-38102 (2011
98. Song B, Wang Y, Xi Y et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28, 4065-4074 (2009
99. Isaacs JT, Antony L, Dalrymple SL et al. Tasquinimod Is an allosteric modulator of HDAC4 survival signaling within the compromised cancer microenvironment. Cancer Res. 73, 1386-1399 (2013